Cover Image for Virtual Global Expert Program: Steven Haken
Cover Image for Virtual Global Expert Program: Steven Haken
27 Went

Virtual Global Expert Program: Steven Haken

Hosted by Perth Biodesign & Perth Biodesign
Virtual
Registration
Past Event
Welcome! To join the event, please register below.
About Event

​Steven Haken is Managing Director of Odelle Technology, a UK and France-based health economics and market access consultancy operating across Europe, Australia, and North America.

​He is a European market access and reimbursement strategist specialising in translating medical innovation into sustainable healthcare adoption.

​For more than two decades, Steven has secured and structured reimbursement pathways across the UK and EU for biotechnology therapeutics, in vitro diagnostics, medical devices, and digital health technologies.

​His work integrates clinical value with rigorous health economic modelling, coding architecture, HTA strategy, and real-world implementation, ensuring that innovation is not only approved but funded and adopted.

​What we'll cover

​This session will begin with a discussion of how to create the Value Analysis Tool, a structured framework that translates clinical benefit into hospital-level economic impact. It can and is used across Australia and the EU, UK.

​In Europe, the CE mark is a regulatory requirement, not a commercial guarantee. Adoption depends on whether a device improves contribution margins within DRG systems, aligns with national HTA logic, and fits procurement realities.

​We'll deep dive into:

  • ​How to determine where your device fits within European reimbursement systems (DRG, outpatient tariff, capital, add-on payment, innovation pathway)

  • ​How to conduct a practical reimbursement analysis before market entry

  • ​The difference between regulatory approval and funded adoption

  • ​UK, Germany (DRG/NUB), France, Spain, Poland, Netherlands, concrete entry routes and decision-makers

  • ​What evidence is required for coding, funding inclusion, or hospital-level adoption

  • ​Why many devices stall despite strong clinical data and how to avoid that trap


​Dates for the Diary:

​Session 2: Chris Molloy, Medicines Discovery Catapult, UK – 18th March, 3.00pm - 4.30pm

​Session 3: Peter Traianou, Emerging Health Connections, USA – 25th March, 9.00am - 10.30am

​Session 4: Jennifer Head, Midnight Health, UK – 22nd April, 1.00pm - 2.30pm


​About the Virtual Global Expert Program

​Getting time with the right expert at the right moment can change the trajectory of a company. We're making that easier to access across WA.

​This program connects WA innovators directly with international experts — people who have built companies, raised capital, navigated regulatory pathways, and opened international markets in the sectors you're working in.

​Five themed virtual sessions with leading global practitioners, plus limited 1:1 office hours available to deep dive further.

​Presented by the WA Life Sciences Innovation Hub, with the support of the Government of Western Australia Department of Energy and Economic Diversification.

27 Went